Speech-Language Pathologists in Woodbury, NY Accepting Medicare

26 Speech-Language Pathologists found. Showing 1 - 20

Marnie Marissa Morabito, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 72 Southwoods Road, Woodbury, NY 11797 Phone: 516-921-7650

Mrs. Eugenia Lorin, M. A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 60 Keri Way, Woodbury, NY 11797 Phone: 917-826-2876    Fax: 516-496-2520

Brittany Sloane Zucker, MS CCC-SLP, TSSLD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 37 Orchard Dr, Woodbury, NY 11797 Phone: 516-713-9422

Mrs. Kimberly Loring Gershon, M.S.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 118 Woody Ln, Woodbury, NY 11797 Phone: 516-458-6063

Ms. Katherine Joyce, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 280 Crossways Park Dr, Woodbury, NY 11797 Phone: 516-938-1784

Jamie Goldstein, CCC-SLP, TSSLD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19 Kristi Ln, Woodbury, NY 11797 Phone: 516-316-3732

Alicia M Elman, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 280 Crossways Park Dr, Woodbury, NY 11797 Phone: 516-686-4496

Katherine Sadis Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8 Swenson Dr, Woodbury, NY 11797 Phone: 516-375-3947

Abbey Lichtenstein-portnoy, M.A.-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 28 Joyce Ln, Woodbury, NY 11797 Phone: 917-854-9194

Kathy Bih Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 103 Aspen Dr E, Woodbury, NY 11797 Phone: 347-645-1116

Kristin Sgroi Esposito Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 280 Crossways Park Dr, Woodbury, NY 11797 Phone: 516-938-1784

Mrs. Celeste Marie Losito, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8 Swenson Dr, Woodbury, NY 11797 Phone: 516-921-5292    Fax: 516-921-5273

Allison Van Ness Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 72 S Woods Rd, Woodbury, NY 11797 Phone: 516-921-7650

Ms. Carly Isabel Saunders Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 33 Caumsett Woods Ln, Woodbury, NY 11797 Phone: 516-998-6680

Mrs. Tina Myerson Jensen, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 280 Crossways Park Dr, Woodbury, NY 11797 Phone: 516-938-1784

Mrs. Christiana Krimitsos, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 482 Woodbury Rd, Woodbury, NY 11797 Phone: 516-364-5823

Ms. Maura S Kolker, MACCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 280 Crossways Park Dr, Woodbury, NY 11797 Phone: 516-938-1784

Mrs. Kelly Michele Behan, M.S., CCC-SLP, TSSLD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 280 Crossways Park Dr, Woodbury, NY 11797 Phone: 516-938-1784

Jeanine Baldassarri, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 280 Crossways Park Dr, Woodbury, NY 11797 Phone: 516-938-1784

Speech Edge, Slp P.c. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8 Elm St, Woodbury, NY 11797 Phone: 516-297-0842

News Archive

Study: Cannabis has no effect in slowing course of progressive multiple sclerosis

The first large non-commercial clinical study to investigate whether the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis (MS), shows that there is no evidence to suggest this; although benefits were noted for those at the lower end of the disability scale.

New treatment for vaso-occlusive crisis in sickle cell patients

GlycoMimetics, Inc. (GMI), a clinical-stage biotechnology company that is developing a new class of glycobiology-based therapies for a broad range of indications, today announced that a pilot study of the company's lead candidate, GMI-1070, is underway in sickle cell patients. The first patients in this pilot study were treated at Children's Hospital & Research Center Oakland in California.

Adamas Pharmaceuticals expands its Phase 2 TCAD therapy study for influenza A

Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has expanded its Phase 2 clinical study of a proprietary investigational triple-combination antiviral drug therapy for influenza to include centers in the United States, Canada and Europe. The study, which was initiated in August 2009 in the Southern Hemisphere, is designed to investigate Adamas' triple combination antiviral drug (TCAD) therapy as a treatment for influenza A, including novel influenza A/H1N1, the cause of the current flu pandemic.

Health interest groups strategize to stop automatic cuts

Industry lobbyists hope the "shock value" of last week's White House report detailing the reach of the cuts will add momentum to efforts to persuade Congress to repeal the legislation before reductions start in January.

Senate confirms Paige Alexander as USAID Assistant Administrator for Europe and Eurasia

On December 22, the United States Senate voted to confirm Paige Alexander as the Assistant Administrator for Europe and Eurasia at the U.S. Agency for International Development (USAID).

Read more Medical News

› Verified 5 days ago

• 1(current)
• 2